← brief for 2026-09-13 · Slowing decline

Designing Clinical Trials for the Treatment of Membranous Nephropathy in the Anti-Phospholipase A2 Receptor 1 Era: Results of a NephCure Membranous Nephropathy Workshop

Paper No results yet Peer reviewed

Key takeaways

Kidney doctors and the patient group NephCure met to agree on how to run better trials in membranous nephropathy, a disease that leaks large amounts of protein into the urine. They focused on using a blood antibody test, anti PLA2R, to choose patients and to judge whether treatment is working. This is a plan for future studies, so there are no results yet.

Who did this work

Brad H. Rovin · Marco Prunotto · Patrick H. Nachman · Aliza M. Thompson · Barbara S. Gillespie (University of North Carolina at Chapel Hill) · Elizabeth A. Stafford · Josh M. Tarnoff · Austin Hu · Laurence H. Beck

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-12
https://doi.org/10.17615/y44v-g138